期刊文献+

多发性骨髓瘤患者肾损害临床特征及其相关因素分析(英文) 被引量:7

Clinical characteristics and correlative factors analysis of multiple myeloma with renal damage
暂未订购
导出
摘要 目的了解多发性骨髓瘤(MM)肾损害患者临床特征及其发生的相关因素。方法对经临床、病理明确诊断的MM肾损害患者的临床特征及实验室检查进行统计学分析。结果MM肾损害的发生率为40.9%(18/44),临床症候群以肾功能不全(血肌酐>177 μmol/L)最为常见(77.8%),其次为肾病综合征(16.7%)、无症状尿检异常(5.56%)。血清轻链阳性率为72.2%(13/18),尿中轻链阳性率为77.8%(14/18例),均以λ链为主。骨髓浆细胞数量和尿本周蛋白(BJP)与肾功能损害之间有显著相关关系(P<0.01;P<0.05),贫血及多发性骨损害与肾脏损害有相关关系(P<0.05)。结论MM伴肾损害患者临床症候群以肾功能不全多见,血清与尿液中轻链以λ为主。骨髓浆细胞增殖及尿轻链蛋白产生可能是多发性骨髓瘤肾脏损害的主要原因。 Objective: To analyze the clinical characteristics and the correlative factors of kidney lesion in 44 cases of multiple myeloma (MM). Methods: From March 1994 to March 2004, 44 patients with MM were diagnosed by clinical characteritics and pathological methods. Analysis of statistics in clinical characteristics and results of laboratory of kidney lesion of this group of patients were carried out. Results: The incidence of kidney lesion was 40.9% (18/44), with 18 patients occurred in 44 cases. Renal insufficiency (Scr>177.0 μmol/L) was the most frequent syndrome (77.8%), followed by nephrotic syndrome (16.7%) and syndrome of urinary abnormalities (5.56%). Free light chain was detected in serum of 13 (13/18) patients, in urine of 14 (14/18) patients, with λ chain as the dominant type. There was significant correlation between the quantity of bone marrow plasmacyte or urinary Bence-Jones protein and renal functional lesion (P<0.01, P<0.05). Anemia or multiple bone lesion was correlated with kidney damage. Conclusions: The most frequent clinical syndrome of MM with renal lesion is renal insufficiency. The λ chain is the dominant type in the serum or urine. Proliferation of bone marrow plasmacyte and the quantity or urinary Benec-Jones protein are main causes of kidney lesion in multiple myeloma.
出处 《中国医学工程》 2004年第4期36-39,共4页 China Medical Engineering
关键词 多发性骨髓瘤 肾损害 肾功能不全 骨髓浆细胞 尿轻链蛋白 细胞增殖 myeloma multiple renal insufficiency clinical analysis
  • 相关文献

参考文献10

  • 1[1]Kyle RA. Plasmacell disorder. In: Harrison'sprinciplesofinternalmedicine(14th)[M]. Faucisa, ed. McGraw. Hill Inc, 1998: 962-965.
  • 2[2]Winearls CG. Acute myeloma kidney[J]. Kidney Int, 1995, 48:1347-1361.
  • 3[3]ZHU HH, XU KL, PAN XY, et al. Clinical analysis of 60 cases of multiple myeloma[J]. Leukemia·Lymphoma, 2002, 11(5): 298-300.Chinese
  • 4[4]Sakhuja V, Jha V, Varma S, et al. Renal involment in multiple myeloma: 10 years study[J]. Ren Fail, 2000, 22(4): 465-477.
  • 5[5]Viertel A, Weidmann E, Ditting T, et al. Management of renal complications in patients with advanced multiple myeloma [J]. Leuk lymphoma, 2000, 38(6): 513-519.
  • 6[6]Herrera GA. Renal manifestations of plasma cell dysctasiasian appraisal from the patients,bedside to the research laboratory[J]. Ann Diagn Pathol, 2000, 4(3): 174-200.
  • 7[7]Knuden LM, Hippe E, Hjorth M, et al. Renal failure in newly diagnosed multiple myeloma-ademoraphicsyudy of 1353 patients[J]. Eur JH aematol, 1994, 53: 207-212.
  • 8[8]Misiani R, Tirabschi G, Mingarde G, et al. Management of myeloma kidney: ananti light chain approach[J]. Am J Kidney Dis, 1987, 10:28-33.
  • 9[9]Blade J, Fernandez Llama P, Bosch F, et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution[J]. Arch Intern Med, 1998, 158:1889-1893.
  • 10[10]Oshima, Kanda Y, Nannya Y, et al. Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma [J].Am J Hematol, 2001, 67(1): 1-5.

同被引文献26

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部